Pharmafile Logo
Pharmafocus logo
Advanced Search
16854249705_06b9d59c29_z

Indian measles vaccination campaign saved tens of thousands of lives

March 6, 2019
Research and Development Asia, India, South Asia, infectious diseases, measles, vaccines

A measles vaccination campaign saved tens of thousands of children’s lives in India between 2010 and 2013, according to a …

News
spravato

Janssen’s party drug-based nasal spray becomes first new FDA-approved depression treatment in 30 years

March 6, 2019
Research and Development, Sales and Marketing Janssen, Spravato, depression, esketamine, pharma

The field of depression therapy has seen its biggest leap forward in over three decades, the FDA approval of Janssen’s …

News

Postoperative radiation can triple survival in children with brain cancer

March 6, 2019
Research and Development brain cancer, children, epndymoma, oncology, paediatric brain cancer, radiation

Radiation immediately following surgery in children with the third most common form of paediatric brain tumour, ependymoma, can triple survival, …

News

Women scientists receive $41,000 less in funding than men, study shows

March 6, 2019
Research and Development NIH, funding, international womens day, management, science, women

Women scientists receive $41,000 less in federal funding than men, according to a study of nearly 54,000 grants to first …

News
antony_loebel

Sunovion CMO Dr Antony Loebel made company’s new CEO

March 5, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, CMO, Japan, medicine, psychiatry, sunovion

Japanese drugmaker Sunovion Pharmaceuticals has made their current Chief Medical Officer (CMO) the company’s new Chief Executive Officer (CEO). Dr …

Appointment
shutterstock_38078521

Akcea and Ionis’ Waylivra nets CHMP approval in ultra-rare familial chylomicronaemia syndrome

March 5, 2019
Manufacturing and Production, Sales and Marketing Akcea, FCS, Ionis, familial chylomicronemia syndrome, pharma, rare disease

Akcea Therapeutics and Ionis Pharmaceuticals have announced that their investigational therapy Waylivra (volanesorsen) has been recommended by the EMA’s Committee …

News
novartis_side_building

Novartis set to offer 14 weeks paternity leave

March 5, 2019
Manufacturing and Production Novartis, company culture, paternity leave, work

Novartis is planning to offer employees 14 weeks of parental leave, a move which would make the firm one of …

News
1920px-hiv-budding-color

London man becomes second in world to be cured of HIV

March 5, 2019
Manufacturing and Production Berlin Patient, CCR5, HIV, He Jiankui, London Patient

A man in Britain has become the second person in the world to be ‘cured’ of HIV, after receiving a …

News
novartis_side_building

Novartis’ Cosentyx tops Janssen’s Stelara in moderate-to-severe psoriasis trial

March 5, 2019
Manufacturing and Production, Research and Development Cosentyx, Janssen, Novartis, Stelara, pharma, psoriasis

New data has been revealed in support of Novartis’ Cosentyx (secukinumab) in the treatment of moderate-to-severe plaque psoriasis, demonstrating the …

News
920x920

OxyContin drugmaker Purdue Pharma exploring bankruptcy, sources say

March 4, 2019
Manufacturing and Production Litigation, Purdue Pharma, bankruptcy, opioid crisis, trials

OxyContin drugmaker Purdue Pharma is exploring the option of filing for bankruptcy. The news comes as the Connecticut-based firm faces …

News

The cutting edge of cancer research

March 4, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, feature, oncology

While immunotherapies continue to be the darling of the industry, new, innovative and sometimes seemingly fantastical research is emerging that …

Feature
abbvie_0

AbbVie’s Skyrizi scoops up CHMP recommendation for moderate to severe plaque psoriasis

March 4, 2019
Sales and Marketing AbbVie, pharma, psoriasis

AbbVie’s interleukin-23 (IL-23) inhibitor Skyrizi (risankizumab) has secured recommendation from the EMA’s Committee for Medicinal Products for Human Use (CHMP), …

News

Indian government set to colour code generic medicines

March 4, 2019
Sales and Marketing India, Indian health, costs, generic medicines, pricing, sales

As part of an effort to promote low cost medicines, the Indian government has announced plans to colour code generic …

News
natural-homeopathic-remedy-alternative-homeopathy-1604071

Doctors call on Canadian government to stop funding programme sending homeopaths to Honduras

March 4, 2019
Sales and Marketing Canada, Hodnuras, Quebec, TSF, health, homeopathy

Canadian physicians have called on the federal government to review its funding for a programme which sends volunteer homeopaths to …

News

Biogen boosts ophthalmology portfolio with $800m acquisition of gene therapy firm Nightstar

March 4, 2019
Sales and Marketing Biogen, Nightstar, acquisition, pharma

Biogen has announced it has inked an agreement to acquire clinical-stage gene therapy firm Nightstar for a total value of …

News

NHS chief warns of rise of anti-vaccine ‘fake news’ online

March 4, 2019
Sales and Marketing NHS, NHS England, Simon Stevens, anti vaxxer, fake news, vaccines

The head of NHS England has warned that ‘vaccination deniers’ are increasing their influence on social media through ’fake news’. …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

March 1, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GP, Michael Cohen, Novartis, Roche, Sanofi, Senate, UK, crispr, top 10

As the CRISPR twins’ story unfolds, scientists revealed that the Chinese babies were likely altered in a way that improves …

News
bernie_in_phoenix_2015_2

Bernie Sanders calls on FDA to allow generic, low cost versions of Catalyst Pharma’s $375,000 rare disease drug

March 1, 2019
Medical Communications Bernie Sanders, Catalyst Pharmaceuticals Jacobus

US Senator Bernie Sanders has called on regulators to allow pharmacies and manufacturers to distribute generic versions of Catalyst Pharmaceuticals’ …

News

J&J sign deal with Scottish firm AdoRx to develop novel lung cancer treatments

March 1, 2019
Medical Communications AdoRx, Cancer, Cancer Immunotherapy, J&J, JJ, immunology, oncology

Edinburgh-based drug discovery firm AdoRx therapeutics has signed a deal with US healthcare conglomerate Johnson & Johnson to develop novel …

News

Philippines Department of Justice recommends charges against six Sanofi officials

March 1, 2019
Medical Communications Philippines, Sanofi, dengue, dengvaxia, vaccines

The Philippine Justice Ministry has said it has found probably cause to charge officials working for French drugmaker Sanofi over …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026